Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2003
09/04/2003WO2003072550A1 Novel fused ring indazole compounds
09/04/2003WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient
09/04/2003WO2003072544A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072140A1 Compression-molded preparions with quick-disintegration properties
09/04/2003WO2003072136A1 Antihypertensive compositions and uses thereof
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072120A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
09/04/2003WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072109A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072096A1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
09/04/2003WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
09/04/2003WO2003072090A2 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072060A2 Polypeptide formulation
09/04/2003WO2003072040A2 Administration of agents for the treatment of inflammation
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2003029244A8 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives
09/04/2003WO2003020273A3 Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
09/04/2003WO2003018743A3 Emu-based formulations for wound treatment
09/04/2003WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
09/04/2003WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
09/04/2003WO2002088106A3 Cysteine protease inhibitors
09/04/2003WO2002079248A3 Mammalian alpha-helical protein-53
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002045723A3 Inflammatory cytokine secretion inhibition with modified mammalian blood
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
09/04/2003US20030167525 Desaturase genes and uses thereof
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166902 Hybrid; process control; genetic engineering
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders
09/04/2003US20030166854 Allelic variant of human STAT3
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166706 Method of treating osteoarthritis
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166694 Glycinamides
09/04/2003US20030166691 Phenylalanine derivatives
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166683 N-(4-carbamimidoyl-phenyl)-glycine derivatives
09/04/2003US20030166680 For treating serine protease or dual-serine protease mediated disorders
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166616 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166585 Substituted tetracycline compounds as synergistic antifungal agents
09/04/2003US20030166582 Aryl fused azapolycyclic compounds
09/04/2003US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
09/04/2003US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166556 Immunoregulator
09/04/2003US20030166548 Synthetic milittin and related peptides derived from the sequence of human phospholipase A2-activating protein (PLAP), free from the contaminating phospholipase A2 (PLA2) and/or present when the peptides are purified from natural sources,
09/04/2003US20030166546 Uses of THANK, a TNF homologue that activates apoptosis
09/04/2003US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions.
09/04/2003US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide
09/04/2003US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents.
09/04/2003US20030166530 Conjugate heat shock protein-binding peptides
09/04/2003US20030166524 Therapeutic uses of IL-1 receptor antagonist
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030166257 Use of Lactobacillus salivarius
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
09/04/2003US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant
09/04/2003US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy
09/04/2003US20030165892 Unigene unidirectional antisense library
09/04/2003US20030165588 Cyclooxygenase inhibitors; antiinflammatory drugs
09/04/2003US20030165569 Composition for topical substance delivery
09/04/2003US20030165558 Antiallergic agent
09/04/2003US20030165510 Antiinflammatory agents; anticancer agents; cholesterol binding protein
09/04/2003US20030165499 Compositions and methods for treating psoriasis
1 ... 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 ... 1272